Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

INDIV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Neoplasms 4Barrett Esophagus 4Uterine Cervical Neoplasms 2Uterine Cervical Dysplasia 2Mouth Neoplasms 2Uterine Neoplasms 1Oral Lesions 1Neoplasms, Squamous Cell 1Mouth Diseases 1Malignant Neoplasms of Female Genital Organs 1Laryngeal Diseases 1Head and Neck Neoplasms 1Gastroesophageal Reflux 1Endometrial Neoplasms 1Colonic Polyps 1Carcinoma, Squamous Cell 1Carcinoma in Situ 1

Interventions

Cisplatin 252Radiotherapy 176Cetuximab 144pembrolizumab 120Docetaxel 96Fluorouracil 92Carboplatin 80Paclitaxel 77Radiotherapy, Intensity-Modulated 69Nivolumab 37Radiation 30Drug Therapy 30Erlotinib Hydrochloride 26Gemcitabine 25Gefitinib 21Cyclophosphamide 21Surveys and Questionnaires 20Surgical Procedures, Operative 19Standard of Care 19Pemetrexed 19durvalumab 18Magnetic Resonance Spectroscopy 17Capecitabine 17Radiosurgery 16Celecoxib 16atezolizumab 15Filgrastim 15Amifostine 15Low-Level Light Therapy 14Everolimus 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Head and Neck Neoplasms × Proflavine × Clear all
NCT01456143 2018-02-01

Optical Imaging of Head and Neck Cancer

Anandasabapathy, Sharmila, M.D.

Phase NA Terminated
33 enrolled 9 charts
Head & Neck

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Laryngeal Diseases, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡